Pharming Group N.V. - ADR

NASDAQ:PHAR 3:34:52 PM EDT

14.52

-0.74 (-4.85%)

7:36:40 PM EDT: $15.00 +0.48 (+3.31%)

Market Cap (Intraday)	994.83M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$98.22 Million
Adjusted EPS	$0.00

See more estimates

10-Day MA	$14.28
50-Day MA	$11.72
200-Day MA	$9.80

See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.